10.1249/01.MSS.0000069553.47739.36
This "use it or lose it" principle suggests that keeping your pituitary active through Sermorelin may help preserve its function long-term
The findings, published in February in The Lancet Obstetrics, Gynaecology, & Women's Health, highlight a possible new strategy for addressing weight gain after menopause, when hormonal shifts can increase the risk of obesity, cardiovascular disease and Type 2 diabetes
Entre los pacientes que persistieron con su medicacin a los 12 meses, la reduccin promedio en el peso corporal fue de -12,9% con semaglutida para la obesidad , en comparacin con -5,9% con semaglutida para la diabetes tipo 2
However, exceeding recommended doses significantly increases the risk of severe gastrointestinal symptoms, dehydration, electrolyte disturbances, and potentially life-threatening complications
L approccio integrato con nutrizionista e medico (dietologo o endocrinologo) potr essere utilizzato solo a determinate condizioni